0001104659-24-033132.txt : 20240311
0001104659-24-033132.hdr.sgml : 20240311
20240311200028
ACCESSION NUMBER: 0001104659-24-033132
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240307
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SELICK HAROLD E
CENTRAL INDEX KEY: 0001287233
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37852
FILM NUMBER: 24739838
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc
CENTRAL INDEX KEY: 0001377121
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 980505495
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
BUSINESS PHONE: (510) 474-0170
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Therapeutics Inc
DATE OF NAME CHANGE: 20130605
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Inc
DATE OF NAME CHANGE: 20061002
4
1
tm248535-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-07
0
0001377121
Protagonist Therapeutics, Inc
PTGX
0001287233
SELICK HAROLD E
C/O PROTAGONIST THERAPEUTICS, INC.
7707 GATEWAY BLVD., SUITE 140
NEWARK
CA
94560-1160
1
0
0
0
0
Common Stock
2024-03-07
4
M
0
6490
1.89
A
27996
D
Stock Option (right to buy)
1.89
2024-03-07
4
M
0
6490
0.00
D
2024-10-22
Common Stock
6490
0
D
The stock option is fully vested.
/s/ Matthew Gosling, Attorney-in-Fact for Harold E. Selick
2024-03-11